Lunit INSIGHT MMG
Breast cancer diagnosis solution that assists physicians in the interpretation of mammograms.
Overview
10 to 30% of breast cancers are still missed when reading mammograms¹ to this day. Lunit INSIGHT MMG aims to improve readers’ performance and ensure early breast cancer detection.
Lunit INSIGHT MMG is a computer-assisted Detection/Diagnosis (CADe/x) software that identifies and classifies suspicious areas for breast cancer on mammograms via deep learning technology. It was trained with a large-scale, high-quality (clinically/CT-proven cases) training dataset of 240,000 cases.
Features
Lunit INSIGHT MMG generates:
• Location of breast cancer in the form of heatmaps and/or contour maps.
• Abnormality Score reflecting the probability of the presence of breast cancer.
• An assessment of breast density (not FDA-cleared).
• Has regulatory clearance in USA, Canada, EU, UK, Australia and New Zealand.
Benefits
- Expected to improve diagnostic accuracy for dense and fatty breasts.
- In a study, a hybrid triage workflow scenario showed a potential 69.5% reduction in workload and a 30.5% reduction in the interval/missed cancer rate.²
- Supports early diagnosis of breast cancer, including interval cancer and next-round screen-detected cancer.²
- Proven potential to replace one of the readers in a double-reading breast cancer screening environment, while improving cancer detection rate and reducing recall rates.³
Image examples
Contour maps
Heat maps
To find out more about Lunit’s solutions, or the 100+ other applications on the Blackford Platform, book a discovery call with our team.
Book a meeting
We’d welcome the opportunity to learn more about your AI needs and to explain how partnering with Blackford can drive efficiency and provide ongoing value.
Book a Meeting¹Majid AS, de Paredes ES, Doherty RD, Sharma NR, Salvador X. Missed breast carcinoma: pitfalls and pearls. Radiographics: A Review Publication of the Radiological Society of North America, Inc [Internet]. 2003 Jul 1;23(4):881–95.